What is Sarepta Therapeutics, Inc.'s net investment in lease?

Sarepta Therapeutics, Inc. (SRPT) reported net investment in lease of $124.06M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s net investment in lease changed year-over-year?

Sarepta Therapeutics, Inc.'s net investment in lease decreased by 15.6% year-over-year, from $147.06M to $124.06M.

What is the long-term trend for Sarepta Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s net investment in lease has grown at a 6.5% compound annual growth rate (CAGR), from $91.76M to $125.5M.

Sarepta Therapeutics, Inc. SRPT Net Investment in Lease

Net Investment in Lease at other companies

PTC TherapeuticsPTCT

——

InsmedINSM

——

Capricor TherapeuticsCAPR

——

Catalyst PharmaceuticalCPRX

——

uniQureQURE

——

Edgewise Therapeutics, Inc.EWTX

——

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s net investment in lease?: Sarepta Therapeutics, Inc. (SRPT) reported net investment in lease of $124.06M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s net investment in lease changed year-over-year?: Sarepta Therapeutics, Inc.'s net investment in lease decreased by 15.6% year-over-year, from $147.06M to $124.06M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s net investment in lease has grown at a 6.5% compound annual growth rate (CAGR), from $91.76M to $125.5M.